[Education--the genuine article].

J. Boesen,I. Carlsen,B. Nielsen,C. Yde,D. Quisgaard,B. Rasmussen,C. Pedersen

1993-03-24

Abstract:

What problem does this paper attempt to address?

Improved Clinical Outcomes Associated with Hungry Bone Syndrome Following Parathyroidectomy in Dialysis Patients

Panida Silarat,Sarunya Saeseow,Adisorn Pathumarak,Praopilad Srisuwaran,Ronnarat Suvikapakornkul,Sinee Disthabanchong

DOI: https://doi.org/10.1016/j.eprac.2024.08.004

2024-08-28

Abstract:Objective: Hungry bone syndrome (HBS) is a common complication after parathyroidectomy in dialysis patients with severe secondary hyperparathyroidism. The rapid decline in parathyroid hormone (PTH) levels diminishes bone resorption and accelerates bone formation. This causes a significant influx of calcium and phosphate into the bone, resulting in severe and prolonged hypocalcemia. While previous studies have established risk factors for HBS, the outcomes beyond the reduced recurrence rate of hyperparathyroidism have been largely unexplored. Methods: This single-center retrospective study analyzed 322 cases in 314 dialysis patients who underwent parathyroidectomy between 2012 and 2022. The study examined baseline factors associated with HBS, adverse events, and clinical outcomes, including changes in blood pressure and hematologic and nutritional parameters over 3-12 months of follow-up, stratified by HBS status. Results: Total parathyroidectomy was performed in 28 cases (8.7%), total parathyroidectomy with implantation in 98 cases (30.4%), and subtotal parathyroidectomy in 196 cases (60.9%). HBS occurred in 207 cases (64%). Independent predictors of HBS included male sex, lower serum calcium levels, higher PTH levels, and lack of active vitamin D treatment at baseline. Patients with HBS had longer hospital stays but did not experience an increase in other adverse events. Following parathyroidectomy, the HBS group showed a greater reduction in blood pressure and more significant increases in hemoglobin, total lymphocyte count, and serum creatinine. This group also saw a more substantial decrease in the proportions of patients with hemoglobin <11 g/dL and serum creatinine/body surface area <380 μmol/L/m2. Although the HBS group showed a more significant decline in PTH levels from baseline, similar proportions achieved the target PTH level by the end of the study. Serum calcium levels remained substantially lower in the HBS group throughout the follow-up, while serum phosphate and PTH levels were comparable. Conclusion: HBS was associated with more pronounced improvements in blood pressure, anemia, and nutritional parameters. The presence of HBS could indicate greater achievement in controlling hyperparathyroidism following parathyroidectomy.
Risk factors for developing hungry bone syndrome after parathyroidectomy for secondary hyperparathyroidism

Min-Jean Yin,Xin Nie,Qianhui Liu,Yanzhao Zhou,Ling Yang,Siyu Chen,Mengmeng Ma,Lan Bai,Yong He,Guixing Li

DOI: https://doi.org/10.21203/rs.3.rs-3471834/v1

2023-01-01

Abstract:Background Parathyroidectomy is recommended for patients with secondary hyperparathyroidism and has been proven to reduce all-cause mortality and cardiovascular mortality. Hungry bone syndrome is a common complication of parathyroidectomy. Therefore, identifying the preoperative risk factor for hungry bone syndrome is meaningful. In this study, we aimed to determine possible risk factors and their thresholds for hungry bone syndrome after parathyroidectomy for patients with secondary hyperparathyroidism. Methods Participants with secondary hyperparathyroidism who underwent parathyroidectomy were finally enrolled in this study. Hungry bone syndrome is defined as immediate postoperative hypocalcemia (calcium ≤ 2.1 mmol/L) and/or prolonged hypocalcemia (> 4 days) after parathyroidectomy. Clinical information and preoperative and postoperative laboratory data were collected. Results In all, 92 participants with secondary hyperparathyroidism who underwent parathyroidectomy were finally enrolled in this study. Among them, 61 patients (66.3%) experienced hungry bone syndrome after parathyroidectomy with a mean age of 44.3 years. Patients who experienced hungry bone syndrome had a higher preoperative parathyroid hormone value (263 (221, 329) vs . 139 (91, 187); P = 0.000) and phosphate value (2.42 ± 0.23 vs. 2.08 ± 0.61; P = 0.003) but a lower preoperative calcium level (2.41 ± 0.18 vs. 2.59 ± 0.20, P = 0.000). Meanwhile, patients with hungry bone syndrome were younger (44.3 years vs 51.9 years, P = 0.003). From the ROC curve, parathyroid hormone had the highest AUC = 0.868 (95% CI, 0.781–0.930) and sensitivity and specificity rates of 0.803 (0.682–0.894) and 0.903 (0.742–0.980), respectively, at a threshold of 215.9 pmol/L. Conclusions Secondary hyperparathyroidism patients with higher preoperative parathyroid hormone and phosphate levels and lower calcium levels were more likely to develop hungry bone syndrome.
Detection of primary and secondary sucrose malabsorption in children by means of the breath hydrogen technique

G. Davidson,T. Robb

DOI: https://doi.org/10.5694/j.1326-5377.1983.tb142082.x

1983-07-01

Abstract:Eighty‐one breath hydrogen tests were performed in 72 children who were investigated either because of chronic diarrhoea or recurrent abdominal pain, or because they were relatives of patients with congenital sucrase‐isomaltase deficiency. The results of tests on 16 patients were positive (sucraseisomaltase deficiency, seven patients; secondary sucrose malabsorption, nine patients). Hydrogen production was higher in patients with sucraseisomaltase deficiency (mean, 96 ppm; range, 20 ppm to 432ppm) than in those with secondary sucrose malabsorption (mean, 21 ppm; range, 12ppm to 51 ppm). All patients with positive test results responded to sucrose restriction, and those with secondary malabsorption subsequently became well. The breath hydrogen test is a sensitive, non‐invasive method for detecting sucrose malabsorption, whether due to a primary deficiency or secondary to other bowel disorders. Guidelines for improving the accuracy and reproducibility of the breath hydrogen test are discussed.
Multiple fractures due to hungry bone syndrome following parathyroidectomy: a clinical case report and review of literature

Farnaz Tavakoli,Fatemeh Yaghoubi,Davood Dalil,Mahdi Rezaei

DOI: https://doi.org/10.1186/s40842-024-00183-8

2024-08-17

Abstract:Background: Hungry bone syndrome (HBS) is defined as prolonged hypocalcemia caused by a sudden decrease in parathyroid hormone (PTH) levels after parathyroidectomy (PTX). Multiple fractures after PTX due to HBS in an end-stage renal disease (ESRD) patient on chronic hemodialysis (HD) are challenging and rare medical conditions presented in this study. Case presentation: A 42-year-old ESRD patient on HD 3 times a week presented to Shariati Hospital, Tehran, Iran, complaining of worsening bone pain and loss of appetite. Laboratory data revealed an intact parathyroid hormone (iPTH) concentration of 2500 pg/mL, an alkaline phosphatase (Alp) level of 4340 IU/L, a phosphorus (P) level of 9 mg/dL, and a calcium (Ca) concentration of 7.2 mg/dL. Sestamibi scintigraphy revealed parathyroid adenoma. The findings suggested tertiary hyperparathyroidism (HPT-III), and the patient was scheduled for total PTX. Approximately one month after surgery, the patient was referred due to convulsions, leg mobility problems, and worsening bone pain. There was bilateral femoral ecchymosis. The Ca concentration was 5.8 mg/dL, and radiological evaluations revealed multiple skeletal fractures. HBS after PTX was suggested for this patient. After several days of hospitalization, he suffered subcutaneous emphysema followed by rib fractures and passed away. Conclusions: Multiple fractures after PTX due to HBS following HPT-III in ESRD patients are rare and demanding, highlighting the necessity of timely diagnosis and management of patients with HPT-III. Severe hypocalcemia following PTX can cause skeletal disorders. However, the surgical treatment of parathyroid adenomas may be more important than the risk of complications associated with bone health.
[The hungry bone syndrome--an update]

St Farese

DOI: https://doi.org/10.1024/0040-5930.64.5.277

Abstract:The Hungry Bone Syndrome (HBS) represents an important cause of prolonged hypocalcemia after parathyreoidectomy (PTX) due to primary, secondary or tertiary hyperparathyreoidism. The sudden postoperative withdrawal of parathyroid hormone (PTH) induces a stop in osteoclastic bone resorption without affecting the osteoblastic activity. Consequently, an increased bone uptake of calcium, phosphate and magnesium is observed. Risk factors for the development of HBS include: Large parathyroid adenomas, age > 60 years, high preoperative levels of serum PTH, calcium and alkaline phosphatase. In these patients a careful monitoring of clinical symptoms of hypocalcemia as well as the laboratory parameters are warranted during the immediate postoperative period. Treatment with oral calcium, and especially in patients with renal failure, additionally active vitamin D should be started as soon as possible after PTX. In severe cases of HBS, the administration of intravenous calcium is necessary. The duration of therapy is governed by symptoms and severity of the HBS and may last for up to 12 or more months. While prevention of HBS in high risk patients includes preoperative Vitamin D, the role of bisphosphonates has yet to be established.
A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy

DOI: https://doi.org/10.1186/s40001-024-01801-y

IF: 4.981

2024-03-29

European Journal of Medical Research

Abstract:Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD). Hungry bone syndrome (HBS) after parathyroidectomy (PTX) is a serious complication, which can lead to diarrhea, convulsion, arrhythmia and even death. This study was aimed to determine the risk factors for HBS after PTX in dialysis patients with SHPT and construct a nomogram prediction model to predict the incidence of postoperative complications.

medicine, research & experimental
Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment

Yu-Chi Kuo,Shang-Yu Wang,Yu-Liang Hung,Chih-Chieh Hsu,Hao-Wei Kou,Ming-Yang Chen,Chun-Yi Tsai,Chih-Hsiang Chang,Yu-Chao Wang,Jun-Te Hsu,Ta-Sen Yeh,Wei-Chen Lee,Chun-Nan Yeh

DOI: https://doi.org/10.3389/fendo.2023.1063837

2023-02-03

Abstract:Background: Secondary hyperparathyroidism (SHPT) is a common condition in patients with end-stage renal disease (ESRD) who are on dialysis. Parathyroidectomy is a treatment for patients when medical therapy has failed. Recurrence may occur and is indicated for further surgery in the era of improved quality of care for ESRD patients. Methods: We identified, 1060 patients undergoing parathyroidectomy from January, 2011 to June, 2020. After excluding patients without regular check-up at our institute, primary hyperparathyroidism, or malignancy, 504 patients were enrolled. Sixty-two patients (12.3%, 62/504) were then excluded due to persistent SHPT even after the first parathyroidectomy. We aimed to identify risk factors for recurrent SHPT after the first surgery. Results: During the study period, 20% of patients who underwent parathyroidectomy at our institute (in, 2019) was due to recurrence after a previous parathyroidectomy. There were 442 patients eligible for analysis of recurrence after excluding patients with the persistent disease (n = 62). While 44 patients (9.95%) had recurrence, 398 patients did not. Significant risk factors for recurrent SHPT within 5 years after the first parathyroidectomy, including dialysis start time to first operation time < 3 years (p = 0.046), postoperative PTH >106.5 pg/mL (p < 0.001), and postoperative phosphorus> 5.9 mg/dL (p = 0.016), were identified by multivariate analysis. Conclusions: The starting time of dialysis to first operation time < 3 years in the patients with dialysis, postoperative PTH> 106.5 pg/mL, and postoperative phosphorus> 5.9 mg/dL tended to have a higher risk for recurrent SHPT within 5 years after primary treatment.
Risk factors for hypocalcemia after parathyroidectomy in maintenance hemodialysis patients with secondary hyperparathyroidism

成铭,黄碧红,陶冶,范春燕,张炜晨,王红鹰,陈靖,张敏敏

DOI: https://doi.org/10.3760/cma.j.cn441217-20210803-00057

2022-01-01

Abstract:Objective:To explore the risk factors of hypocalcemia and the correlation between calcium supplementation and clinical parameters after parathyroidectomy (PTX) in maintenance hemodialysis patients with secondary hyperparathyroidism (SHPT), and to analyze the effect of calcium supplementation after PTX on the long-term prognosis of patients.Methods:This study was a single-center retrospective study. The patients who underwent PTX in maintenance hemodialysis patients with SHPT in the Huashan Hospital affiliated to Fudan University from October 2014 to March 2021 were retrospectively enrolled. Total PTX with auto transplantation or total PTX alone were the surgical procedures. According to the postoperative requirement of calcium in the first week, the patients were divided into two groups: high calcium supplement (>16.05 g/week) group and low calcium supplement group (≤16.05 g/week). According to the average serum calcium level in the first week after operation, the patients were divided into hypocalcemia group (≤2.1 mmol/L) and non-hypocalcemia group (>2.1 mmol/L) and the differences of clinical parameters between the two groups were compared. The correlation between clinical parameters and the postoperative calcium requirement was examined through Pearson or Spearman correlation analysis. The influencing factors for hypocalcemia after PTX were examined through logistic regression analysis. The survival curve was made by Kaplan-Meier method, and the difference of cumulative survival rate between the two groups was compared by log-rank test.Results:A total of 98 maintenance hemodialysis patients with SHPT were enrolled. The levels of serum calcium, phosphorus, and intact parathyroid hormone (iPTH) after the operation decreased significantly than those of preoperation (all P<0.05). Multiple linear regression analysis showed age ( β=-0.160, P=0.030), iPTH ( β=0.004, P=0.025) and C-reactive protein ( β=0.186, P=0.011) were correlated with postoperative calcium requirement. Preoperative alkaline phosphatase ( OR=1.002, 95% CI 1.000-1.004, P=0.018) and hemoglobin ( OR=0.977, 95% CI 0.954-1.000, P=0.048) independently predicted the occurrence risk of postoperative hypocalcemia through multivariate logistic regression analysis. The recurrence rate of high calcium supplement group was higher than that of low calcium supplement group (10.26% vs 0, P=0.023) and there was no significant difference in all-cause mortality between the two groups (17.95% vs 5.08%, P=0.086). The recurrence rate between the hypocalcemia group and non-hypocalcemia group was no significantly different (8.3% vs 1.8%, P=0.451) and there was no significant difference in all cause mortality between the two groups (12.5% vs 12.7%, P=1.000). Kaplan-Meier survival curve showed that the cumulative survival rate between the two groups was no significantly different (log-rank test χ2=0.147, P=0.702). Conclusions:PTX is a safe and effective therapeutic method to reduce the level of iPTH and improve the metabolism of calcium and phosphorus in SHPT patients. Age, iPTH and C-reactive protein are correlated with the postoperative requirement of calcium in the first week. Preoperative alkaline phosphatase and hemoglobin are independent risk factors for postoperative hypocalcemia. Correcting preoperative electrolyte disorder, improving infection and anemia can reduce the incidence of hypocalcemia after PTX.
Persistent secondary hyperparathyroidism caused by parathyromatosis and supernumerary parathyroid glands in a patient on haemodialysis

Jun Yang,Jun Zhang,Ning-hu Liu,Hao Liu,Meng-jie Dong

DOI: https://doi.org/10.1186/s12882-020-01917-3

2020-01-01

BMC Nephrology

Abstract:Background Secondary hyperparathyroidism (SHPT) is a common high-risk factor for mortality in end-stage renal disease, and parathyromatosis and supernumerary parathyroid glands are very rare causes of persistent SHPT. Preoperative diagnosis and removal of all hyperplastic parathyroid glands are challenging. We report a rare case of persistent SHPT due to parathyromatosis and supernumerary parathyroid glands and successful management by multiple imaging modalities. Case presentation A 53-year-old Chinese woman on haemodialysis experienced discomfort due to itching and bone pain due to persistent SHPT after parathyroidectomy. The supernumerary parathyroid glands and parathyromatosis were detected by multiple imaging modalities, including 99m Tc-sestamibi ( 99m Tc-MIBI) scans, ultrasonography and four-dimensional computed tomography (4D-CT) and then excised; pathological confirmation was performed. During follow-up, her serum calcium and parathyroid hormone levels were stable in the appropriate ranges, and no complications arose. Conclusions Because of persistent SHPH after parathyroidectomy in patients with haemodialysis, multiple imaging modalities, including 99m Tc-MIBI scans, 4D-CT and ultrasonography, are helpful for detecting supernumerary parathyroid glands and parathyromatoses. Accurate preoperative localization of this rare lesion is important for management, enabling the removal of all affected parathyroid tissues.
Can We Predict Who Will Develop Postoperative Hyperkalaemia after Parathyroidectomy in Dialysis Patients with Secondary Hyperparathyroidism?

Yu-Huan Song,Guang-Yan Cai,Yue-Fei Xiao,Yi-Ping Wang,Song-Tao Yang,Xiang-Mei Chen

DOI: https://doi.org/10.1186/s12882-019-1416-9

2019-01-01

BMC Nephrology

Abstract:Hyperkalaemia occurs frequently in many maintenance haemodialysis (MHD) patients after parathyroidectomy (PTX) with secondary hyperparathyroidism (SHPT). However, the clinical risk factors that predict postoperative hyperkalaemia are uncertain. This retrospective cohort study included 90 maintenance haemodialysis patients aged ≥18 years who underwent PTX between April 2011 and April 2016 at Aerospace Center Hospital (Peking University Aerospace School of Clinical Medicine). Pre- and post-PTX surgery venous samples were measured in quadruplicate. We examined univariate associations with demographics, dialysis characteristics, laboratory values and medications. Hyperkalaemia was defined as serum potassium >5.3 mmol/L. Out of nighty patients, twenty-two (24.4%) developed postoperative hyperkalaemia, of whom sixteen (18.1%) developed hyperkalaemia on postoperative day 3. The univariate analysis showed that weight, dialysis duration, preoperative serum potassium, alkaline phosphate, triglyceride, and postoperative alkaline phosphate were independently associated with hyperkalaemia after parathyroidectomy. The univariate logistic regression model showed that preoperative serum potassium was the only independent factor that could predict hyperkalaemia after parathyroidectomy (odds ratio, 1.59; 95% confidence interval, 1.24-2.05). The optimal cut-off for pre-operative K was 3.9 mmol/L according to the receiver operating characteristic (ROC) curve. A higher incidence of postoperative hyperkalaemia was found in male and younger patients, but the difference was not statistically significant (p>0.05). Pre-operative serum potassium less than 3.9 mmol/L was associated with less hyperkalaemia post-operatively in end-stage renal disease (ESRD) patients undergoing PTX.
Prognosis and factors related to severe secondary hyperparathyroidism in long-term peritoneal dialysis patients

Yanmei Li,Xiaonan Feng,Na Chen,Shuhua Song,Min Yu,Yan Wang,Hongxia Zhang,Li Wang,Menghua Chen,Na Tian

DOI: https://doi.org/10.1080/0886022x.2024.2356022

IF: 3.222

2024-05-29

Renal Failure

Abstract:Secondary hyperparathyroidism (SHPT) can progress to severe SHPT (sSHPT), which affects the survival rate and quality of life of patients. This retrospective cohort study investigated risk factors for sSHPT and the association between SHPT and mortality (all-cause and infection-related) among 771 clinically stable patients (421 male patients; mean age, 51.2 years; median dialysis vintage, 28.3 months) who underwent >3 months of regular peritoneal dialysis (PD) between January 2013 and March 2021. The sSHPT and non-sSHPT groups comprised 75 (9.7%) (median progression, 35 months) and 696 patients, respectively. sSHPT was defined as a serum intact parathyroid hormone (PTH) level >800 pg/mL observed three times after active vitamin D pulse therapy. The influence of sSHPT on the prognosis of and risk factors for sSHPT progression were evaluated using logistic and Cox regression analyses. After adjusting for confounding factors, higher (each 100-pg/mL increase) baseline PTH levels (95% confidence interval (CI) 1.206–1.649, p < .001), longer (each 1-year increase) dialysis vintages (95% CI 1.013–1.060, p = .002), higher concomitant diabetes rates (95% CI 1.375–10.374, p = .010), and lower (each 1-absolute unit decrease) Kt / V values (95% CI 0.859–0.984, p = .015) were independent risk factors for progression to sSHPT in patients on PD. During follow-up, 211 deaths occurred (sSHPT group, n = 35; non-sSHPT group, n = 176). The sSHPT group had significantly higher infection-related mortality rates than the non-sSHPT group (12.0% vs. 4.3%; p < .05), and sSHPT was associated with increased infection-related mortality. In conclusion, patients with sSHPT are at higher risk for death and infection-related mortality than patients without sSHPT.

urology & nephrology
Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).

M. Krant,D. M. Iszard,A. Abadi,R. Carey

1962-09-01

Abstract:
Plasma Metabolite Biomarkers Related to Secondary Hyperparathyroidism and Parathyroid Hormone.

Qixia Shen,Wenyu Xiang,Sen Ye,Xin Lei,Lefeng Wang,Sha Jia,Xue Shao,Chunhua Weng,Xiujin Shen,Yucheng Wang,Shi Feng,Lihui Qu,Cuili Wang,Jianghua Chen,Ping Zhang,Hong Jiang

DOI: https://doi.org/10.1002/jcb.28846

2019-01-01

Journal of Cellular Biochemistry

Abstract:Background Hyperphosphatemia, hypocalcemia, and elevation of parathyroid hormone (PTH) are typical abnormalities of uremic patients with Secondary hyperparathyroidism (SHPT). However, metabolic imbalance associated with SHPT is not well understood. Methods A total of 15 SHPT patients with an intact parathyroid hormone (iPTH) level > 600 pg/mL were set as preoperative (PR) group, 15 age- and gender-matched controls who had undergone parathyroidectomy plus forearm transplantation because of hyperparathyroidism and achieved an iPTH level <150 pg/mL were set as postoperative (PO) group. Metabolite profiling of these 30 uremic patients and five healthy controls (HC) was performed using ultra performance liquid chromatography-mass spectrometry. Results Five differential metabolites, including allyl isothiocyanate, L-phenylalanine, D-Aspartic acid, indoleacetaldehyde, and D-galactose correlated with PTH were identified in this study. Taking them as a biomarker signature, PR group can be distinguished from HC group with an area under the curve (AUC) of 0.947 (95% CI, 0.76-1) and PO group with an AUC of 0.6 (95% CI, 0.38-0.807). Conclusions The serum metabolome correlated with PTH is successfully demonstrated for a better understanding of the pathogenesis of SHPT.
P1429EVALUATION OF PARATHYROIDECTOMY IN PERSISTENT HYPERARATHYROIDISM AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY

Ping Zhang,Hulin Lu,Jianghua Chen

DOI: https://doi.org/10.1093/ndt/gfaa142.p1429

IF: 7.1857

2020-01-01

Nephrology Dialysis Transplantation

Abstract:Abstract Background and Aims To investigate the efficacy of parathyroidectomy (PTX) in the treatment of persistent hyperparathyroidism (PHPT) after renal transplantation and the effect of PTX on renal allograft function. Method This single-center retrospective study enrolled 31 patients who underwent PTX for the treatment of PHPT after renal transplantation in the Kidney Disease Center of the First Affiliated Hospital of Zhejiang University from May 2010 to Oct. 2018. The changes of serum calcium, serum phosphorus, alkaline phosphatase, parathyroid hormone(PTH), serum creatinine, and estimated glomerular filtration rate (eGFR) in the preoperative and postoperative periods (1w, 1m, 3m, 6m,12m) were compared. The operative successful rate (12 m) and postoperative complications were calculated. Results The serum calcium before PTX was (2.78±0.18) mmol/L, which decreased significantly to (2.19±0.34) mmol/L at 1 week postoperatively (P<0.01). The serum phosphorus before PTX was (0.76±0.16) mmol/L, which decreased significantly to (0.97±0.26) mmol/L at 1 week postoperatively (P<0.01). The PTH before PTX was (276.00±200.60) pg/mL, which decreased significantly to (46.62±104.36) pg/mL at 1 week postoperatively (P<0.01). The alkaline phosphatase before PTX was (261.59±236.95) U/L, which decreased significantly to (154.90±117.37) U/L at 3 months postoperatively (P<0.01). No significant difference was found in postoperative serum creatinine or eGFR levels compared with the baseline. The operative successful rate was 90.3% at 12 months postoperatively. The incidence rates of postoperative transient hypocalcemia, persistent hypoparathyroidism, and hoarseness were 35.5%, 3.2% and 3.2% respectively. No persistent hypocalcemia, incision hemorrhage, incision infection, or surgery-related death happened. Conclusion PTX can quickly and effectively alleviate high calcium, low phosphorus, high PTH and high alkaline phosphatase after renal transplantation. PTX is effective and safe in the treatment of PHPT after renal transplantation, and has no effect on renal allograft function.
RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Siyu Chen,Yang Chen,Bing Pan,Wei Zhao,Hong Jiang,Jianghua Chen,Ping Zhang

DOI: https://doi.org/10.21203/rs.3.rs-3567207/v1

2023-01-01

Abstract:Background/aim Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), the mechanisms of cell proliferation leading to which has not been fully understood in recent years. And this study investigated the potential genes of tissue proliferation in secondary hyperparathyroidism. Materials and methods RNA sequencing (RNA-Seq) analysis was conducted to explore the potentially related genes of SHPT. Patients with secondary hyperparathyroidism indicated for surgical parathyroidectomy in our institution were reviewed and the parathyroid glands were removed for RNA-Seq analysis to measure the differential changes of RNA expression. Furthermore, we validated the differential genes expression by quantitative real-time PCR (qRT-PCR) in tissue samples and enzyme-linked immunosorbent assay (ELISA) in the serum of patients with or without SHPT. Results Our study identified 24 DEGs by RNA-Seq, among which 16 were upregulated and 8 were downregulated. Through the qRT-PCR, we further found that U2AF1L5, LTBP2, RGN in the hyperplasia group were significantly downregulated and RAP1GAP2 was significantly upregulated compared to the control group. And only Serum U2AF1L5 concentrations in patients with SHPT were significantly higher than those in healthy controls (0.360.27ng/ml vs 0.150.07ng/ml, P<0.05) as ELISA showed. Conclusion The genes including LTBP2, RGN, RAP1GAP2 and U2AF1L5 differentially expressed in tissues and serum in patients with SHPT.
Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study

Wenqiang Qiu,Ge Zhou

DOI: https://doi.org/10.1186/s12893-023-02143-y

2023-08-12

Abstract:Purpose: Parathyroidectomy (PTX) is commonly performed as a treatment for secondary hyperparathyroidism (SHPT) in patients with end-stage renal disease (ESRD). We aimed to evaluate the efficacy of PTX in patients with SHPT who underwent hemodialysis. Methods: This retrospective study analyzed the clinical treatment of 80 hemodialysis patients with SHPT who underwent either total PTX with forearm auto transplantation (TPTX + AT) or subtotal parathyroidectomy (SPTX). We compared the changes in biochemical indices before and after surgery as well as the attenuation of intact parathyroid hormone (iPTH) in the TPTX and SPTX groups. We also evaluated clinical symptoms and quality of life using the Visual Analog Scale (VAS) and the Short Form-36 Questionnaire (SF-36) before and at 3, 6, and 12 months after surgery. Results: Serum iPTH and serum phosphorus levels decreased significantly after surgery in 80 patients with SHPT (P < 0.05). Within one month of surgery, there was a difference in iPTH levels between the TPTX + AT and SPTH groups, but there was no difference over time. Patients experienced significant improvement in their clinical symptoms of restless leg syndrome, skin itching, bone pain, and joint pain at 1 week post operation (P < 0.001). Quality of life significantly improved after surgery, as assessed by SF-36 scores (P < 0.05). Hypocalcemia was the most common postoperative complication, occurring in 35% of patients. Within the first 12 months post surgery, 5 patients had a recurrence. Conclusion: PTX is effective in rapidly reducing iPTH levels, improving calcium and phosphorus metabolism disorders, and enhancing patients' quality of life by safely and effectively relieving clinical symptoms.
Clinical Observation of Parathyroidectomy in Uremic Patients with Secondary Hyperparathyroidism

柯剑婷,朱伟平,陈剑,陈家湄,李杰,杜艺,李宓

DOI: https://doi.org/10.3969/j.issn.1673-7555.2009.29.008

2009-01-01

Abstract:Objective To investigate the clinical feature,pathogenesis of secondary hyper-parathyroidism(SHPT)and parathyroidectomy in uremic patients.Methods Three patients undergone parathyroidectomy due to uremic SHPT were reported retrospectively:preoperative and postoperative clinical manifestations,results of lab testing,imaging and pathologic biopsy.To discuss the pathogenesis and surgical treatment with literature.Results Three patients had different levels of musculoskeletal,skin malaise and ectopic calcification.Serum calcium,phosphorus and PTH concentration increased.Different skeletal disorders were seen with X-ray.Nodular hyperplasia or adenoma of parathyroid were found in color ultrasonograph and pathologic biopsy.Most of these lesions improved after surgery.Conclusion Uremic SHPT may cause multiple-system lesions.Parathyroidectomy should be chosen when medical treatment is invalid.
Effect of Parathyroidectomy on Anemia and Cardiac Function in Uremic Patients with Secondary Hyperparathyroidism

Ying Shen,Ping Zhang,Hua Jiang,Jianghua Chen

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2018.05.001

2018-01-01

Abstract:Objective To explore the effect of total parathyroidectomy (PTX) with forearm autograft on the anemia and cardiac function in uremic patients with secondary hyperparathyroidism (SHPT).Methods The clinical data of 130 uremic patients who received PTX with forearm autograft in the First Affiliated Hospital of Zhejiang University from October 2010 to December 2015 were retrospectively analyzed.The changes of anemia and echocardiogram before and after operation were compared.According to the presence of left ventricular hypertrophy (LVH) before operation,the patients were divided into LVH group and non-LVH group.Echocardiographic indexes before and one year after operation of the two groups were compared.Results (1) Three months and one year after operation,hemoglobin and hematocrit increased while erythropoietin average usage decreased significantly (P＜0.01).(2) Compared with preoperative period,the dry weight was significantly increased one year after operation,and the cardiac function indexes including left ventricular end diastolic diameter (LVDd),interventricular septum end diastolic thickness (IVSd),left ventricular posterior wall end diastolic thickness (LVPWd),interventricular septum systolic thickness (IVSs),left ventricular systolic diameter (LVDs),left ventricular myocardial mass (LVM),and left ventricular myocardial mass index (LVMI) decreased significantly (P ＜ 0.05).(3) In the non-LVH group,only IVSs decreased one year after operation (P ＜ 0.05).In the LVH group,LVDs,LVDd,LVPWd,LVM,LVMI and IVSs were decreased significantly one year after operation than those in preoperative period (P ＜ 0.05).Conclusions PTX with forearm autograft is an effective treatment for uremic patients with SHPT significantly improving anemia and left ventricular structure and function,especially for patients with ventricular hypertrophy in preoperative.
Impact of Different Levels of Ipth on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy

Qiu Ping Xi,Xi Sheng Xie,Ling Zhang,Rui Zhang,Yue Fei Xiao,Cheng Gang Jin,Yan Bo Li,Lin Wang,Xiao Xuan Zhang,Shu Tong Du

DOI: https://doi.org/10.1155/2017/6934706

2017-01-01

BioMed Research International

Abstract:Background. Secondary hyperparathyroidism (SHPT) usually required parathyroidectomy (PTX) when drugs treatment is invalid. Analysis was done on the impact of different intact parathyroid hormone (iPTH) after the PTX on all-cause mortality. Methods. An open, retrospective, multicenter cohort design was conducted. The sample included 525 dialysis patients with SHPT who had undergone PTX. Results. 404 patients conformed to the standard, with 36 (8.91%) deaths during the 11 years of follow-up. One week postoperatively, different levels of serum iPTH were divided into four groups: A: ≤20 pg/mL; B: 21–150 pg/mL; C: 151–600 pg/mL; and D: >600 pg/mL. All-cause mortality in groups with different iPTH levels appeared as follows: A (8.29%), B (3.54%), C (10.91%), and D (29.03%). The all-cause mortality of B was the lowest, with D the highest. We used group A as reference (hazard ratio (HR) = 1) compared with the other groups, and HRs on groups B, C, and D appeared as 0.57, 1.43, and 3.45, respectively. Conclusion. The all-cause mortality was associated with different levels of iPTH after the PTX. We found that iPTH > 600 pg/mL appeared as a factor which increased the risk of all-cause mortality. When iPTH levels were positively and effectively reducing, the risk of all-cause mortality also decreased. The most appropriate level of postoperative iPTH seemed to be 21–150 pg/mL.
Factors influencing serum calcium levels and the incidence of hypocalcemia after parathyroidectomy in primary hyperparathyroidism patients

Yongliang Mu,Yishen Zhao,Jiannan Zhao,Qi Zhao,Yushuai Zhang,Yang Li,Jiedong Kou,Gianlorenzo Dionigi,Xuehai Bian,Hui Sun

DOI: https://doi.org/10.3389/fendo.2023.1276992

IF: 6.055

2023-12-05

Frontiers in Endocrinology

Abstract:Background: Parathyroidectomy (PTX) is an effective treatment for primary hyperparathyroidism (PHPT) patients. Postoperative hypocalcemia is a common complication after PTX. This study aimed to analyze the factors influencing serum calcium levels and the incidence of hypocalcemia after parathyroidectomy in primary hyperparathyroidism patients. Methods: The retrospective study included 270 PHPT patients treated with PTX and collected their demographic and clinical information and their laboratory indices. Factors influencing serum calcium levels and hypocalcemia after PTX in PHPT patients were analyzed using univariate and multifactorial analyses. Results: First, in patients with normal preoperative serum calcium levels (2.20–2.74 mmol/L), the higher the preoperative alkaline phosphatase and serum phosphorus levels, the lower the postoperative serum calcium levels. Furthermore, the higher the preoperative serum calcium levels and the accompanying clinical symptoms, the higher the postoperative serum calcium levels. Low preoperative serum calcium levels were shown to be a risk factor for postoperative hypocalcemia (OR=0.022), and the optimal preoperative serum calcium threshold was 2.625 mmol/L (sensitivity and specificity were 0.587 and 0.712, respectively). Second, in the mild preoperative hypercalcemia group (2.75-3.00 mmol/L), the older the patient, the higher the preoperative and postoperative serum calcium levels, the higher the postoperative serum calcium; the lower the alkaline phosphatase and calcitonin levels, the higher the postoperative serum calcium levels. On the other hand, the younger the patient was, the more likely hypocalcemia blood was (OR=0.947), with an optimal age threshold of 47.5 years (sensitivity and specificity were 0.543 and 0.754, respectively). Third, in the preoperative moderate to severe hypercalcemia group (>3.0mmol/L), patients undergoing a combined contralateral thyroidectomy and a total thyroidectomy had low postoperative serum calcium levels. Conclusion: Patients with different preoperative serum calcium levels had various factors influencing their postoperative serum calcium levels and postoperative hypocalcemia, which facilitated the assessment of their prognosis.

endocrinology & metabolism

[Education--the genuine article].

Improved Clinical Outcomes Associated with Hungry Bone Syndrome Following Parathyroidectomy in Dialysis Patients

Risk factors for developing hungry bone syndrome after parathyroidectomy for secondary hyperparathyroidism

Detection of primary and secondary sucrose malabsorption in children by means of the breath hydrogen technique

Multiple fractures due to hungry bone syndrome following parathyroidectomy: a clinical case report and review of literature

[The hungry bone syndrome--an update]

A nomogram prediction model for hungry bone syndrome in dialysis patients with secondary hyperparathyroidism after total parathyroidectomy

Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment

Risk factors for hypocalcemia after parathyroidectomy in maintenance hemodialysis patients with secondary hyperparathyroidism

Persistent secondary hyperparathyroidism caused by parathyromatosis and supernumerary parathyroid glands in a patient on haemodialysis

Can We Predict Who Will Develop Postoperative Hyperkalaemia after Parathyroidectomy in Dialysis Patients with Secondary Hyperparathyroidism?

Prognosis and factors related to severe secondary hyperparathyroidism in long-term peritoneal dialysis patients

Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).

Plasma Metabolite Biomarkers Related to Secondary Hyperparathyroidism and Parathyroid Hormone.

P1429EVALUATION OF PARATHYROIDECTOMY IN PERSISTENT HYPERARATHYROIDISM AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY

RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study

Clinical Observation of Parathyroidectomy in Uremic Patients with Secondary Hyperparathyroidism

Effect of Parathyroidectomy on Anemia and Cardiac Function in Uremic Patients with Secondary Hyperparathyroidism

Impact of Different Levels of Ipth on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy

Factors influencing serum calcium levels and the incidence of hypocalcemia after parathyroidectomy in primary hyperparathyroidism patients